| Ischemic stroke | fucoxanthin | anti-OS | inhibit OS via Nrf2/HO-1 signaling pathway |
| Sirtuin 6 |
| protocatechualdehyde |
| mangiferin |
| Korean Red Ginseng |
| 11-Keto-β-boswellic acid |
| metformin |
| S-allyl cysteine |
| monomethyl fumarate |
| dieckol |
| fumarate |
| ursolic acid | upregulate Nrf2 pathway and expression levels of BDNF |
| HP-1c | AMPK-Nrf2 pathway activation, without any toxicity after penetrating the brain |
| andrographolide | up-regulate Nrf2/HO-1 expression via regulation of p38 MAPK |
| 2,2,6,6-tetramethyl-1-piperidinoxyl | inhibit p38 MAPK and p53 cascades |
| 3H-1,2-Dithiole-3-thione | suppress microglia activation; inhibit CNS peripheral cell infiltration |
| 3-n-butylphthalide | anti-OS; attenuate mitochondrial dysfunction | inhibit OS; activate Nrf2/HO-1/AMPK pathway; improve MMP and complexes I-IV |
| melatonin | activate SIRT1 signaling |
| progesterone | suppress mtROS production and block MPTP |
| 5-methoxyindole-2-carboxylic acid | increase antioxidative capacity via the Nrf2 signaling pathway; reduce OS |
| SkQR1 | protect mitochondria |
| GK | anti-OS; protect blood vessels | faciliate angiogenesis through HIF-1α/VEGF and JAK2/STAT3 pathway |
| leonurine | upregulate VEGF expression by Nrf-2 pathway |
| astragaloside IV | anti-OS; protect BBB | Nrf2 signaling pathway |
| Tao Hong Si Wu Decoction | anti-OS |
| schizandrin A | anti-OS; anti-inflammation | AMPK/Nrf2 pathway |
| tryptanthrin | decrease pro-inflammatory cytokines in BV2 microglia cells via Nrf2/HO-1 signaling and NF-κB |
| 3, 14, 19-triacetyl andrographolide | inhibit TLR4/NF-κB; upregulate Nrf2/ARE |
| quercetin | suppress LPS-induced oxidant production and expression of adhesion molecules |
| apelin 13 | affect AMPK/GSK-3β pathway activated by AR/Gα/PLC/IP3/CaMKK signaling; |
| diosgenin | suppress TLR4/MyD88/NF-kB-induced inflammation |
| irisin | regulate ROS-NLRP3 inflammation |
| TPEN | inhibit OS and inflammation |
| N-acetyl lysyltyrosylcysteine amide |
| Tanshinone IIA |
| berberine | reduce the infarct volume and brain edema; improve motor function; |
| melilotus officinalis | reduce cerebral thrombosis and inflammatory mediators |
| DHC | protect BBB; inhibit inflammation by affecting ROS, NOX2, NOX4, NF-ĸB, and NO |
| resveratrol | modulate intestinal flora-mediated Th17/Tregs and Th1/Th2 polarity shift |
| EPO-cyclosporine | suppress the innate immune response to OS, inflammation and MAPK family signaling |
| rhein | anti-OS; anti-apoptosis | inhibit OS and apoptosis |
| deuterohemin His peptide-6 |
| acteoside |
| radix scrophulariae |
| pomalidomide |
| clostridium butyricum |
| adiponectin | attenuate mitochondrial vulnerability through the JAK2/STAT3 pathway |
| YiQiFuMai | reduce PKCδ/Drp1-mediated mitochondrial fission |
| withania somnifera | inhibit PARP1-AIF-Mediated caspase-independent apoptosis |
| SMXZF | suppress H2O2-induced neuronal apoptosis through caspase-3/ROCK1/MLC pathway |
| diallyl trisufide | suppress OGD-induced apoptosis via the PI3K/Akt-mediated Nrf2/HO-1 signaling pathway |
| plumbagin | anti-OS; anti-inflammation; anti-apoptosis | inhibit OS, inflammation and apoptosis |
| hollow prussian blue nanozymes |
| geniposide |
| curcumin |
| hexahydrocurcumin |
| Sirt3 | promote autophagy | regulate the AMPK-mTOR pathway; decrease H2O2; increase ATP generation |
| β-arrestin-1 | interact two major components of the BECN1 autophagic core complex |
| vitexin | anti-autophagy | inhibit autophagy through the mTOR/Ulk1 pathway |
| silibinin | suppress the mitochondrial and autophagic cell death pathways |
| 3-methyladenine | inhibit expression of LC3 and Beclin-1 |
| astragalosides | block OGD-R-induced apoptosis and autophagy by inhibiting OS and ER stress |
| isoquercetin | anti-OS; anti-inflammation; anti-apoptosis; anti-autophagy | influence TLR4, NF-κB and caspase-1; ERK1/2, JNK1/2, and MAPK; TNF-α, IL-1β and IL-6; NOX4/ROS/NF-κB signaling pathway; CREB, Bax, Bcl-2, and caspase-3 |
| ECGG | affect PI3K/AKT/eNOS and NRF2/HO-1 signaling pathway; promote neovascularization and cell proliferation |
| ICH | green tea | anti-OS | reduce EBI |
| cofilin |
| mammalian sterile 20-like kinase-1 |
| melatonin | reduce DNA damage and MPTP opening |
| dexmedetomidine | inhibit PGC-1α pathway inactivation and mtROS |
| oleuropein | alleviate brain edema; preserve the BBB |
| adiponectin |
| isoliquiritigenin | anti-OS; anti-inflammation | ROS/NF-κB, NLRP3 inflammasome pathway and Nrf2-mediated activities |
| Sirt3 | suppress NLRP3 and IL-1β levels |
| Sodium Benzoate | anti-OS; anti-apoptosis | regulate DJ-1/Akt/IKK/NFκB pathway to inhibit neuronal apoptosis and mtROS |
| carnosine | decrease brain edema, BBB disruption, OS and neuronal apoptosis |
| metformin | anti-OS; anti-inflammation; anti-apoptosis; | inhibit OS, apoptosis and neuroinflammation |
| baicalein |
| hydrogen gas |
| protocatechuic acid |
| hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD) metalloenzymes | abolish ATF4-dependent neuronal death |
| SAH | dimethyl formamide | anti-OS | improve EBI and cognitive dysfunction via the Keap1-Nrf2-ARE system |
| telmisartan | anti-OS; inhibit cerebral vasospasm | decrease TXNIP expression |
| nebivolol | increase GSH-Px activity |
| curcumin | reduce TNF-α |
| curcumin nanoparticles | anti-OS; anti-inflammation | keep BBB integrity; activate glutamate transporter-1; inhibit inflammation and OS |
| UA | suppress the TLR4-mediated inflammatory pathway |
| pterostilbene | inhibit NLRP3 inflammasome and Nox2-related OS |
| apigenin | anti-OS; anti-apoptosis | inhibit EBI through the dual effects of anti-oxidation and anti-apoptosis |
| peroxiredoxin1/2 |
| docosahexaenoic acid |
| sodium hydrosulfide |
| cysteamine |
| gastrodin |
| naringin |
| progesterone |
| AVE 0991 | decreases OS and neuronal apoptosis through Mas/PKA/p-CREB/UCP-2 pathway |
| allicin | extenuate brain edema and BBB dysfunction; |
| mangiferin | anti-OS; anti-inflammation; anti-apoptosis | regulate the mitochondrial apoptosis pathway, NLRP3 and NF-κB. |
| memantine | inhibit inflammation-mediated BBB breakdown and ER stress-based apoptosis |
| Salvianolic acid B | activate Nrf2 signaling pathway |
| Salvianolic acid A | associate with Nrf2 signaling, the phosphorylation of ERK and P38 MAPK signaling |
| mitoquinone | promote autophagy | activate mitophagy via Keap1/Nrf2/PHB2 (prohibitin 2) pathway |
| melatonin | promote autophagy | stimulate autophagy to inhibit apoptotic death of neural cells |